If you are an allergist that accepts UHC commercial plans in your office/facility? Then this blog post is for you!

What is new?

• UHC will consider IgE in vitro allergy serum testing for any patient 20 years and older that have a Dx of moderate to severe asthma or symptoms of allergic bronchopulmonary aspergillosis.
• UHC will consider upto 20 allergen specific antibodies IgE tests per year- any patient 20 years and older

What will not be considered for reimbursement?

• ALCAT
• bead-based epitope assays- in vitro allergy testing
• basophil activation flow cytometry testing billed for allergy symptoms
• IgE multiple screening non specific allergen testing
• IgG, IgA, IgM and IgD in vitro testing with Dx of allergy symptoms

The new reimbursement policy will go into the effect for any DOS on 9/1/26 and thereafter except the following states: AR, CO, KY, NC, NE, OH and RI- for these states the effective date will be 10/1/26.

Find this information useful? Follow my blog for more payer updates.

• UHC commercial plans- new allergy testing policy-9/1/26
• Aetna SGRT reimbursement update
• Anthem BCBS telehealth claims update -9/1/26
• Healthfist: Newly released AMA codes 7/1/26- prior auth info
• Highmark BCBS: home sleep study billing